This evidence supports our finding that deletion of CEACAM1 suppressed ischemic or hypoxic cardiomyocyte apoptosis and reduced the mortality rate due to cardiac rupture during the acute phase after MI in mice. This evidence concerns the gene CEACAM1 and myocardial infarction.